Plunkett Research Online: Adaptive Biotechnologies Corporation

ADAPTIVE BIOTECHNOLOGIES CORPORATION (ADPT:NAS) Company Profile, Corporate Revenues, Growth, Market Size, Analysis, Business Forecasts, Market Share, Metrics, SWOT

Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection .....



Adaptive Biotechnologies Corporation
Ticker: ADPT
Exchange: NAS
Parent Company:
Year Established:
Employees:
Fiscal Year Ends in

Phone: 206 659-0067
Fax: 206 659-0667
Address: 1165 Eastlake Avenue East
Seattle, WA 98109 United States

Map
Types Of Business
Industry Ranks

Industry NAICS code:

In-Vitro Diagnostic Substance Manufacturing
Immune System Assay
Cell Sequencing
Cell Monitoring
Contacts Description
Chad RobinsCEO/Chairman of the Board/Co-Founder/Director
Kyle PiskelCFO/Chief Accounting Officer
See More
Adaptive Biotechnologies Corp is a company advancing the field of immune-driven medicine by harnessing the inherent biology of the adaptive immune system to transform the diagnosis and treatment of disease. Its clinical diagnostic product, clonoSEQ, is a test authorized by the FDA for the detection .....See More See More

Auditor: EY
Legal Advisor:
$USD, In whole numbers,
except marked * or %
202520242023202220212020
Financials
    Revenue
    Cost of Revenue
    Gross Margin %
    R&D Expense
    Operating Income
    Operating Margin %
    SGA Expense
    Net Income
    Earnings Per Share
    Dividends
    Book Value Per Share
    Operating Cash Flow
    Capital Expenditure
    Free Cash Flow
Profitability
    EBITDA
    Return on Assets %
    Return on Equity %
    Net Margin %
    Assets Turnover
    Financial Leverage
Brands, Divisions and Affiliates Top Salaries
immunoSEQ
clonoSEQ
NameTitleSalary (US$)Bonus (US$)
Other Thoughts Corporate Culture

Apparent Female Officers or Directors: